172 related articles for article (PubMed ID: 14678517)
1. Alteration of the fragile histidine triad gene early in carcinogenesis: an update.
Ishii H; Ozawa K; Furukawa Y
J Exp Ther Oncol; 2003; 3(6):291-6. PubMed ID: 14678517
[TBL] [Abstract][Full Text] [Related]
2. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
3. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
4. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
[TBL] [Abstract][Full Text] [Related]
5. Alterations of common chromosome fragile sites in hematopoietic malignancies.
Ishii H; Furukawa Y
Int J Hematol; 2004 Apr; 79(3):238-42. PubMed ID: 15168591
[TBL] [Abstract][Full Text] [Related]
6. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
[TBL] [Abstract][Full Text] [Related]
7. The role of the FHIT/FRA3B locus in cancer.
Huebner K; Garrison PN; Barnes LD; Croce CM
Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
[TBL] [Abstract][Full Text] [Related]
8. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
[TBL] [Abstract][Full Text] [Related]
9. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
Guidi E; Uboldi C; Ferretti L
Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
[TBL] [Abstract][Full Text] [Related]
11. Do FHIT gene alterations play a role in human solid tumors?
Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
[TBL] [Abstract][Full Text] [Related]
12. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of
Simón-Carrasco L; Pietrini E; López-Contreras AJ
Cell Cycle; 2024 Jan; 23(1):92-113. PubMed ID: 38234243
[TBL] [Abstract][Full Text] [Related]
16. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.
Matsuyama A; Shiraishi T; Trapasso F; Kuroki T; Alder H; Mori M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14988-93. PubMed ID: 14630947
[TBL] [Abstract][Full Text] [Related]
17. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma.
Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M
Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422
[TBL] [Abstract][Full Text] [Related]
18. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
19. Chromosome arm 8p and cancer: a fragile hypothesis.
Birnbaum D; Adélaïde J; Popovici C; Charafe-Jauffret E; Mozziconacci MJ; Chaffanet M
Lancet Oncol; 2003 Oct; 4(10):639-42. PubMed ID: 14554243
[TBL] [Abstract][Full Text] [Related]
20. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
